PinkStar Technologies is building an AI-powered decision support platform for breast MRI, aiming to help radiologists detect breast cancer earlier and with more confidence. The company, founded in collaboration with Sheba Medical Center, is preparing a $3 million raise to complete R&D, secure FDA clearance, expand its team, and prepare for a US market launch.
The platform addresses a specific clinical gap: breast MRI is highly sensitive for cancer detection, especially in women with dense breasts or elevated risk, but interpreting the scans requires significant expertise. PinkStar's tool is designed to integrate directly into radiologists' existing workflows rather than replace them.
Founders and technology
The company is led by CEO Sivan Sadan, CMO Prof. Miri Sklair, and CTO Dr. Debbie Anaby. Their approach targets the complexity of breast MRI interpretation, which remains a bottleneck even for experienced radiologists.
PinkStar notes that while many AI companies in breast imaging focus on mammography, none currently offer a commercial AI decision support tool for breast MRI in the US market. That positions the startup in a relatively open field.
Market opportunity and funding
The company estimates the global market for its initial products at $6 billion, with the US opportunity around $2.5 billion. Its target customers are hospitals and imaging centers.
PinkStar has raised $1 million in SAFEs from embARC Ventures and other investors. The company employs nine people and has open positions in medical imaging and other areas.
Why this matters for healthcare professionals
For radiologists and imaging center administrators, the practical takeaway is workflow integration. PinkStar's platform is being built to fit into existing reading workflows, which matters because AI tools that require radiologists to change how they work tend to see low adoption. The company's focus on breast MRI also fills a gap that mammography-focused AI tools don't address - particularly relevant for the growing number of patients with dense breast tissue who are referred for supplemental MRI screening.
Your membership also unlocks:
